NLS PHARMACEUTICS LTD's ticker is NLSPW and the CUSIP is H57830111. A total of 8 filers reported holding NLS PHARMACEUTICS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $49,000 | +28.9% | 194,060 | 0.0% | 0.03% | +36.4% |
| Q2 2022 | $38,000 | -48.6% | 194,060 | -0.3% | 0.02% | -35.3% |
| Q1 2022 | $74,000 | -23.7% | 194,560 | 0.0% | 0.03% | -29.2% |
| Q4 2021 | $97,000 | -39.8% | 194,560 | 0.0% | 0.05% | -33.3% |
| Q3 2021 | $161,000 | -8.5% | 194,560 | 0.0% | 0.07% | +10.8% |
| Q2 2021 | $176,000 | -4.9% | 194,560 | 0.0% | 0.06% | -27.8% |
| Q1 2021 | $185,000 | – | 194,560 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 170,100 | $17,895 | 0.12% |
| Altium Capital Management LP | 200,000 | $21,040 | 0.01% |
| ARMISTICE CAPITAL, LLC | 500,000 | $52,600 | 0.00% |
| CLEAR STREET LLC | 8,600 | $1 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Hudson Bay Capital Management LP | 200,000 | $21,040 | 0.00% |